
FUJIFILM Holdings Corporation
4901.TJPXHealthcareMedical - Devices
Latest quote
¥3,281
+¥64.00 · +1.99%
4901.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteFUJIFILM Holdings Corporation is a global enterprise dedicated to the development, manufacturing, sales, and servicing of an extensive range of solutions, categorized into imaging, healthcare, materials, and business innovation. Its Healthcare division provides a comprehensive suite of products and services designed for prevention, diagnosis, and treatment. These offerings include medical devices, biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicine, and cosmetics and dietary supplements. The Materials segment focuses on industrial applications, supplying inkjet digital presses and printing plates for the printing sector, along with industrial inkjet products and print heads. It also offers data storage media and archiving solutions for digital information management, as well as advanced materials for displays, touch panels, semiconductors, image sensors, and functional films. Within the Business Innovation segment, the company delivers office-oriented devices and services, such as digital multifunction machines, printers, software, and cloud-based solutions. It further provides workflow optimization tools for graphical communications companies and offers tailored document services, including system integration and business process outsourcing, to meet diverse business requirements. The Imaging segment covers both traditional photography and advanced optical technologies. It features products like color films, instant cameras, photo developing and printing systems, color papers, and photo printing services. Additionally, this segment produces high-quality optics, including lenses for TV and cinema production, surveillance cameras, industrial inspection, and projectors. Founded in 1934, FUJIFILM Holdings Corporation is headquartered in Tokyo, Japan.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Teiichi Goto
- Listed since
- May 16, 1949
- Employees
- 73,526
Market position
- Volume
- 5.9M
- 1.07× average
- Average volume
- 5.5M
- Average daily volume
- Market cap
- 3.92T JPY
- Beta
- 0.38
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 4.43T JPY
- P/E (TTM)
- 15.17×
- P/B (TTM)
- 1.01×
- P/S (TTM)
- 1.14×
- EV / EBITDA
- 8.11×
- Earnings yield
- 7.75%
- Free cash flow yield
- -3.11%
- Dividend yield
- 2.13%
Profitability & efficiency
- Gross margin
- 40.20%
- Operating margin
- 9.50%
- Net margin
- 7.58%
- Return on equity
- 7.21%
- Return on assets
- 4.57%
- Return on invested capital
- 5.15%
Financial health
- Debt / equity
- 0.28×
- Current ratio
- 1.37×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.36T JPY | 3.2T JPY | 2.96T JPY | 2.86T JPY | 2.53T JPY |
| Cost of goods sold | 1.99T JPY | 1.9T JPY | 1.77T JPY | 1.72T JPY | 1.49T JPY |
| Gross profit | 1.37T JPY | 1.3T JPY | 1.19T JPY | 1.14T JPY | 1.03T JPY |
| Research and development | 157.79B JPY | 163.4B JPY | 157.11B JPY | 154.15B JPY | 150.53B JPY |
| Selling, general, and administrative | 861.51B JPY | 806.53B JPY | 752.43B JPY | 710.7B JPY | 653B JPY |
| Operating expenses | 1.02T JPY | 969.92B JPY | 909.54B JPY | 864.85B JPY | 803.52B JPY |
| Interest income | 11.22B JPY | 13.38B JPY | 12.23B JPY | 7.67B JPY | 4.65B JPY |
| Interest expense | 4.99B JPY | 8.75B JPY | 8.48B JPY | 5.01B JPY | 2.32B JPY |
| Depreciation and amortization | 172.37B JPY | 163.57B JPY | 150.01B JPY | 142.22B JPY | 133B JPY |
| Operating income | 350.21B JPY | 330.16B JPY | 276.73B JPY | 273.08B JPY | 229.7B JPY |
| Net income | 276.74B JPY | 260.95B JPY | 243.51B JPY | 219.42B JPY | 211.18B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 5 misses, 0 met estimates
- Average EPS surprise
- -3.84%
- 11 comparable reports
- Latest EPS result
- 31.26
- Estimate 47.74 · Miss by 34.52%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥70.00
2025 complete year+95.3% since 2021
2026 partial: ¥35.00
¥35.8333
2,021
¥38.3333
2,022
¥46.6666
2,023
¥56.6666
2,024
¥70.00
2,025
¥35.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥37.50Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥37.50Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥35.00Semi-Annual | Mar 31, 2026 | Jun 29, 2026 |
Dividend | Sep 29, 2025 | ¥35.00Semi-Annual | Sep 30, 2025 | Dec 2, 2025 |
Dividend | Mar 28, 2025 | ¥35.00Semi-Annual | Mar 31, 2025 | Jun 30, 2025 |
Dividend | Sep 27, 2024 | ¥30.00Annual | Sep 30, 2024 | Dec 3, 2024 |
Ex-dividend Sep 29, 2026
¥37.50
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥37.50
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥35.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 29, 2026
Ex-dividend Sep 29, 2025
¥35.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 2, 2025
Ex-dividend Mar 28, 2025
¥35.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 30, 2025
Ex-dividend Sep 27, 2024
¥30.00
Annual
Record Sep 30, 2024 · Payment Dec 3, 2024
4901.T peers
ETFs holding 4901.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core Nikkei 225 ETF1329.T10.35B0.49%2.12T JPY0.05%¥6,789-0.77%
iShares Core TOPIX ETF1475.T9.83B0.34%2.89T JPY0.05%¥417.7-0.07%
iShares JPX-Nikkei 400 ETF1364.T2.88B0.48%592.34B JPY0.05%¥3,7610.00%
Vanguard Total International Stock ETFVXUS409.32M0.06%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA272.86M0.09%315B USD0.03%$73.42+0.80%
iShares Core MSCI EAFE ETFIEFA167.83M0.09%195.14B USD0.07%$100.85+0.86%
iShares MSCI Japan ETFEWJ97.79M0.43%22.49B USD0.49%$95.18+0.97%
JPMorgan BetaBuilders Japan ETFBBJP79.81M0.42%18.96B USD0.19%$76.87+0.97%
iShares Core Nikkei 225 ETF1329.T- Market value
- 10.35B
- Weight
- 0.49%
- AUM
- 2.12T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥6,789-0.77%
iShares Core TOPIX ETF1475.T- Market value
- 9.83B
- Weight
- 0.34%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥417.7-0.07%
iShares JPX-Nikkei 400 ETF1364.T- Market value
- 2.88B
- Weight
- 0.48%
- AUM
- 592.34B JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥3,7610.00%
Vanguard Total International Stock ETFVXUS- Market value
- 409.32M
- Weight
- 0.06%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 272.86M
- Weight
- 0.09%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
iShares Core MSCI EAFE ETFIEFA- Market value
- 167.83M
- Weight
- 0.09%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.85+0.86%
iShares MSCI Japan ETFEWJ- Market value
- 97.79M
- Weight
- 0.43%
- AUM
- 22.49B USD
- Expense ratio
- 0.49%
- Price / 1D
- $95.18+0.97%
JPMorgan BetaBuilders Japan ETFBBJP- Market value
- 79.81M
- Weight
- 0.42%
- AUM
- 18.96B USD
- Expense ratio
- 0.19%
- Price / 1D
- $76.87+0.97%
Continue in GoAI
Research 4901.Tresearch.disclaimer





